Anne Pohrt

Ms. Anne Pohrt

Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Safety and Health at Work
Verified
Journal Article
Open access
Hermann BurrHermann Burr
Hermann Burr
Hanne BerthelsenHanne Berthelsen
Hanne Berthelsen
SMSalvador Moncada
Salvador Moncada
MNMatthias Nübling
Matthias Nübling
EDEmilie Dupret
Emilie Dupret
Anne PohrtAnne Pohrt
Anne Pohrt
A new third version of the Copenhagen Psychosocial Questionnaire (COPSOQ III) has been developed in response to trends in working life, theoretical concepts, and international experience. A key component of the COPSOQ III is a defined set of mandatory core items to be included in national short, middle, and long versions of the questionnaire. The aim of the present article is to present and test the reliability of the new international middle version of the COPSOQ III. The questionnaire was tested among 23,361 employees during 2016-2017 in Canada, Spain, France, Germany, Sweden, and Turkey. A total of 26 dimensions (measured through scales or single items) of the middle version and two from the long version were tested. Psychometric properties of the dimensions were assessed regarding reliability (Cronbach α), ceiling and floor effects (fractions with extreme answers), and distinctiveness (correlations with other dimensions). Most international middle dimensions had satisfactory reliability in most countries, though some ceiling and floor effects were present. Dimensions with missing values were rare. Most dimensions had low to medium intercorrelations. The COPSOQ III offers reliable and distinct measures of a wide range of psychosocial dimensions of modern working life in different countries; although a few measures could be improved. Future testing should focus on validation of the COPSOQ items and dimensions using both qualitative and quantitative approaches. Such investigations would enhance the basis for recommendations using the COPSOQ III.

11 October 2020 in Cancers
Verified
Journal Article
Open access
PDF file
GDGabor Dobos
Gabor Dobos
Anne PohrtAnne Pohrt
Anne Pohrt
CRCaroline Ram-Wolff
Caroline Ram-Wolff
Céleste LebbéCéleste Lebbé
Céleste Lebbé
JBJean-David Bouaziz
Jean-David Bouaziz
AMAdèle De Masson
Adèle De Masson
Cutaneous T-cell lymphomas (CTCL) are a heterogenous group of rare diseases. Many studies have reported on local epidemiology or geographic clustering, however we lack information from a global perspective. A systematic review and meta-analysis was conducted in Medline and the Cochrane Library based on a previously registered protocol and according to the preferred reporting of items for systematic reviews and meta-analyses (PRISMA). We selected publications that enrolled at least 100 patients with primary cutaneous lymphomas according to the current classifications. The relative frequencies (proportions) of subtypes were compared between studies and geographic regions in a meta-analysis. In total, 26 studies met our inclusion criteria, reporting on altogether 16,953 patients. Within primary cutaneous lymphomas, CTCL appeared to be 15% more frequent in Asian populations. Mycosis fungoides (MF) accounted for 62% of CTCL, with an important heterogeneity in frequencies between studies and continents. The proportion of Sézary syndrome (SS) was 3%, stable worldwide. Rare CTCL, such as NK/T-cell lymphoma or subcutaneous panniculitis-like lymphoma, were more frequent in Asian studies. This global meta-analysis of CTCL confirmed the predominance of CTCL among primary cutaneous lymphomas (83% on average) in the three analyzed continents, most of which were MF cases. It revealed the same proportions of SS across continents, and the heterogeneity of MF frequencies, suggesting the possible role of environmental factors in the pathophysiology of the latter. Registration number: CRD42020148295 (PROSPERO).

1 July 2018 in Journal of Affective Disorders
Verified
Journal Article
Closed access
WDWei Duan-Porter
Wei Duan-Porter
DHDaniel Hatch
Daniel Hatch
JPJane F. Pendergast
Jane F. Pendergast
GFGabriele Freude
Gabriele Freude
URUwe Rose
Uwe Rose
GPGuy Potter
Guy Potter

1 May 2020 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
AMAnika Mueller
Anika Mueller
CSClaudia D Spies
Claudia D Spies
RERahel Eckardt
Rahel Eckardt
BWBjörn Weiss
Björn Weiss
Anne PohrtAnne Pohrt
Anne Pohrt
MSMaren Schmidt
Maren Schmidt

13 April 2017 in International Archives of Occupational and Environmental Health
Verified
Journal Article
Open access
PDF file
MMMatthias Möhner
Matthias Möhner
Anne PohrtAnne Pohrt
Anne Pohrt
JGJohannes Gellissen
Johannes Gellissen
Background While occupational exposure to respirable silica is known to lead to lung disease, most notably silicosis, its association with chronic kidney disease is unclear. Objectives This review explores the association between occupational exposure to respirable silica and chronic non-malignant renal disease such as glomerulonephritis. The evidence has been collected and compiled. Possible sources of bias are thoroughly discussed. Methods Cohort studies with silica exposure and case–control studies of renal disease were searched in PubMed until January 2015. Two authors independently abstracted data; any disagreement was resolved by consulting a third reviewer. A meta-analysis was performed to evaluate the association to silica exposure. Results A total of 23 cohort and four case–control studies were included in the analysis. The meta-analysis of cohort studies yielded elevated overall SMRs for renal disease. Some studies, however, included dose–response analyses, most of which did not show a positive trend. The approaches and results of the case–control studies were very heterogeneous. Conclusions While the studies of cohorts exposed to silica found elevated SMRs for renal disease, no clear evidence of a dose–response relationship emerged. The elevated risk may be attributed to diagnostic and methodological issues. In order to permit a reliable estimation of a possible causal link, exposed cohorts should be monitored for renal disease, as the information from mortality studies is hardly reliable in this field.

19 May 2022 in Chest
Verified
Journal Article
Closed access
CFCharles Feldman
Charles Feldman
CSCharles L. Sprung
Charles L. Sprung
SMSpyros D. Mentzelopoulos
Spyros D. Mentzelopoulos
Anne PohrtAnne Pohrt
Anne Pohrt
CHChristiane S. Hartog
Christiane S. Hartog
GRGuy A. Richards
Guy A. Richards
1